Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Year: 2023
Type: review
Source: The Lancet Oncology
Authors: Wanda Cui, Rodney P Rocconi, Ramya Thota, Richard A Anderson, Suanna S Bruinooge, Ioanna A Comstock, Neelima Denduluri, Audrey Gassman, Julie Gralow, Karla J Hutt, Laleh Amiri-Kordestani, Matteo Lambertini, John Leighton, Karen H Lu, Sogol Mostoufi-Moab, Teri Pollastro, Shan Pradhan, Haleh Saber, Caroline Schenkel, Daniel Spratt, Suparna Wedam, Kelly-Anne Phillips
Institutions: The University of Melbourne, Peter MacCallum Cancer Centre, University of Mississippi Medical Center, Intermountain Healthcare, Intermountain Medical Center, MRC Centre for Reproductive Health, University of Edinburgh, American Society of Clinical Oncology, United States Food and Drug Administration, Center for Drug Evaluation and Research, AstraZeneca (United States), Monash University, Ospedale Policlinico San Martino, University of Genoa, The University of Texas MD Anderson Cancer Center, Children's Hospital of Philadelphia, Breast Cancer Alliance, Moffitt Cancer Center
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4387246267